Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology

Behavioural Pharmacology

Volumn 21, Issue 5-6, 2010, Pages 420-426

  Stewart, Adam ^a   Wong, Keith ^a   Cachat, Jonathan ^a   Elegante, Marco ^a   Gilder, Tom ^a   Mohnot, Sopan ^a   Wu, Nadine ^a   Minasyan, Anna ^b   Tuohimaa, Pentti ^b   Kalueff, Allan V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

genetic polymorphisms; hypovitaminosis D; mutant mouse models; neurobehavioral disorders; vitamin D; vitamin D receptor

Indexed keywords

CALCITRIOL; NEUROSTEROID; VITAMIN D;

AGING; ANIMAL BEHAVIOR; BRAIN CALCIFICATION; BRAIN FUNCTION; CALCIUM METABOLISM; COGNITION; DEMENTIA; DEPRESSION; DISEASE PREDISPOSITION; EPILEPSY; HUMAN; MOOD DISORDER; MOTOR DYSFUNCTION; NEURITIS; NONHUMAN; OXIDATIVE STRESS; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY;

ANIMALS; BRAIN; BRAIN DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; MENTAL DISORDERS; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 77955983257     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32833c850f     Document Type: Review

References (112)

1. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH (2001). Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Mol Endocrinol 15:1127-1139.
2. Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA (2004). Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38:1002-1005.
3. Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, et al. (2007). Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 7:769-780.
4. Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, Yeh J (2010). The relative influence of calcium intake and vitamin d status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. [Epub ahead of print]
5. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O (2009). Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 16:1083-1089.
6. Arbelle JE, Chen H, Gaead MA, Allegretto EA, Pike JW, Adams JS (1996). Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant new world primate cells. Endocrinology 137:786-789.
7. Armbrecht HJ, Hodam TL, Boltz MA, Partridge NC, Brown AJ, Kumar VB (1998). Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology 139:3375-3381.
8. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB (2007). Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 26:551-554.
9. Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, et al. (2009). Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 15:203-212.
10. Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, Walker NM, et al. (2007). Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616-2621.
11. Banerjee P, Chatterjee M (2003). Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem 253:247-254.
12. Barnard K, Colon-Emeric C (2010). Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 8:4-33.
13. Becker A, Eyles DW, McGrath JJ, Grecksch G (2005). Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res 161:306-312.
14. Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, Dodd S (2007). Vitamin D deficiency may play a role in depression. Med Hypotheses 69:1316-1319.
15. Bertone-Johnson ER (2009). Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 67:481-492.
16. Bjorkman M, Sorva A, Tilvis R (2008). Vitamin D supplementation has no major effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. Aging Clin Exp Res 20:316-321.
17. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM (2001). Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21:98-108.
18. Brunoni AR, Nakata AC, Tung TC, Busatto GF (2009). Vitamin D-resistant rickets type II-A, basal ganglia calcification, and catatonia: a casual or causal relationship? Psychosomatics 50:420-424.
19. Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL (2009). Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 64:888-895.
20. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, et al. (2010). 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74:18-26.
21. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A (2005). Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157:299-308.
22. Camadoo L, Tibbott R, Isaza F (2007). Maternal vitamin D deficiency associated with neonatal hypocalcaemic convulsions. Nutr J 6:23.
23. Cannell JJ (2008). Autism and vitamin D. Med Hypotheses 70:750-759.
24. Cantorna MT (2006). Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 92:60-64.
25. Cantorna MT (2008). Vitamin D and multiple sclerosis: an update. Nutr Rev 66:S135-S138.
26. Carswell S (1997). Vitamin D in the nervous system: actions and therapeutic potential. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. San-Diego: Academic Press, pp. 1197-1211.
27. Chen L, Davey Smith G, Evans DM, Cox A, Lawlor DA, Donovan J, et al. (2009). Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review. Cancer Epidemiol Biomarkers Prev 18:2874-2881.
28. Chu TT, Liu Y, Kemether E (2009). Thalamic transcriptome screening in three psychiatric states. J Hum Genet 54:665-675.
29. Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, et al. (2007). Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158:1-235.
30. Currenti SA (2010). Understanding and determining the etiology of autism. Cell Mol Neurobiol 30:161-171.
31. D'Alesio A, Garabedian M, Sabatier JP, Guaydier-Souquieres G, Marcelli C, Lemacon A, et al. (2005). Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Hum Mol Genet 14:3539-3548.
32. Davies G, Welham J, Chant D, Torrey EF, McGrath J (2003). A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr Bull 29:587-593.
33. De Abreu DA, Nivet E, Baril N, Khrestchatisky M, Roman F, Feron F (2010). Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res 208:603-608.
34. De Mooij-van Malsen AJ, van Lith HA, Oppelaar H, Hendriks J, de Wit M, Kostrzewa E, et al. (2009). Interspecies trait genetics reveals association of Adcy8 with mouse avoidance behavior and a human mood disorder. Biol Psychiatry 66:1123-1130.
35. Deligiannidis KM, Freeman MP (2010). Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin North Am 33:441-463.
36. Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, et al. (2009). Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev 18:2540-2548.
37. Drag LL, Bieliauskas LA (2010). Contemporary review 2009: cognitive aging. J Geriatr Psychiatry Neurol 23:75-93.
38. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F (2003). Vitamin D3 and brain development. Neuroscience 118:641-653.
39. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005). Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21-30.
40. Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, Feron F (2007). Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 103:538-545.
41. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P, et al. (2009). Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 34 (Suppl 1):S247-S257.
42. Fang Y, Van Meurs JB, Bergink AP, Hofman A, Van Duijn CM, van Leeuwen JP, et al. (2003). Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 18:1632-1641.
43. Feldman SR, Liguori A, Kucenic M, Rapp SR, Fleischer AB Jr, Lang W, Kaur M (2004). Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol 51:45-51.
44. Fernandes de Abreu DA, Eyles D, Feron F (2009). Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34 (Suppl 1):S265-S277.
45. Feron F, Burne TH, Brown J, Smith E, McGrath JJ, Mackay-Sim A, Eyles DW (2005). Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65:141-148.
46. Galbiati F, Polastri L, Thorens B, Dupraz P, Fiorina P, Cavallaro U, et al. (2003). Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells. Endocrinology 144:1832-1841.
47. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002). New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100-105.
48. Gloth FM III, Alam W, Hollis B (1999). Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 3:5-7.
49. Grady CL, Craik FI (2000). Changes in memory processing with age. Curr Opin Neurobiol 10:224-231.
50. Grecksch G, Ruthrich H, Hollt V, Becker A (2009). Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats. Psychoneuroendocrinology 34 (Suppl 1):S258-S264.
51. Hamamoto H, Kusudo T, Urushino N, Masuno H, Yamamoto K, Yamada S, et al. (2006). Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats. Mol Pharmacol 70:120-128.
52. Handoko HY, Nancarrow DJ, Mowry BJ, McGrath JJ (2006). Polymorphisms in the vitamin D receptor and their associations with risk of schizophrenia and selected anthropometric measures. Am J Hum Biol 18:415-417.
53. Hayes CE, Cantorna MT, DeLuca HF (1997). Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 216:21-27.
54. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW (2008). Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 65:508-512.
55. Janjoppi L, Katayama MH, Scorza FA, Folgueira MA, Brentani M, Pansani AP, et al. (2008). Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res Bull 76:480-484.
56. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K (2008). Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264:599-609.
57. Kalueff AV, Tuohimaa P (2007). Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 10:12-19.
58. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P (2004). Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 15:1271-1274.
59. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P (2005a). Abnormal behavioral organization of grooming in mice lacking the vitamin D receptor gene. J Neurogenet 19:1-24.
60. Kalueff AV, Minasyan A, Tuohimaa P (2005b). Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 67:156-160.
61. Kalueff A, Loseva E, Haapasalo H, Rantala I, Keranen J, Lou YR, et al. (2006a). Thalamic calcification in vitamin D receptor knockout mice. Neuroreport 17:717-721.
62. Kalueff AV, Keisala T, Minasyan A, Kuuslahti M, Miettinen S, Tuohimaa P (2006b). Behavioural anomalies in mice evoked by 'Tokyo' disruption of the Vitamin D receptor gene. Neurosci Res 54:254-260.
63. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P (2006c). Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett 394:69-73.
64. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P (2006d). The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disord Drug Targets 5:363-371.
65. Keilhoff G, Grecksch G, Becker A (2010). Haloperidol normalized prenatal vitamin D depletion-induced reduction of hippocampal cell proliferation in adult rats. Neurosci Lett 476:94-98.
66. Keisala T, Minasyan A, Jarvelin U, Wang J, Hamalainen T, Kalueff AV, Tuohimaa P (2007). Aberrant nest building and prolactin secretion in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 104:269-273.
67. Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, Pyykko I, Tuohimaa P (2009). Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115:91-97.
68. Kesby JP, Burne TH, McGrath JJ, Eyles DW (2006). Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol Psychiatry 60:591-596.
69. Kesby JP, Cui X, O'Loan J, McGrath JJ, Burne TH, Eyles DW (2010). Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology (Berl) 208:159-168.
70. Ko P, Burkert R, McGrath J, Eyles D (2004). Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Brain Res Dev Brain Res 153:61-68.
71. Kong J, Zhang Z, Li D, Wong KE, Zhang Y, Szeto FL, et al. (2008). Loss of vitamin D receptor produces polyuria by increasing thirst. J Am Soc Nephrol 19:2396-2405.
72. Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG, van Heemst D (2009). VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30:466-473.
73. Lansdowne AT, Provost SC (1998). Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 135:319-323.
74. Lee CK, Weindruch R, Prolla TA (2000). Gene-expression profile of the ageing brain in mice. Nat Genet 25:294-297.
75. Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, O'Connor DB, et al. (2009). Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 80:722-729.
76. Lewis DA, Hashimoto T (2007). Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons. Int Rev Neurobiol 78:109-131.
77. Lips P (2010). Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. [Epub ahead of print]
78. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, et al. (2004). A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 151:193-197.
79. Manber R, Allen JJ, Morris ME (2002). Alternative treatments for depression: empirical support and relevance to women. J Clin Psychiatry 63:628-640.
80. McCann JC, Ames BN (2008). Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22:982-1001.
81. McGrath J (1999). Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 40:173-177.
82. McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Jarvelin MR, et al. (2004). Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 67:237-245.
83. McGrath J, Iwazaki T, Eyles D, Burne T, Cui X, Ko P, Matsumoto I (2008). Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency. PLoS One 3:e2383.
84. Minasyan A, Keisala T, Lou YR, Kalueff AV, Tuohimaa P (2007). Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 104:274-280.
85. Minasyan A, Keisala T, Zou J, Zhang Y, Toppila E, Syvala H, et al. (2009). Vestibular dysfunction in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 114:161-166.
86. Ogunkolade WB, Boucher BJ, Bustin SA, Burrin JM, Noonan K, Mannan N, Hitman GA (2006). Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing 'betel nut' (Areca catechu) and vitamin D status. J Clin Endocrinol Metab 91:2612-2617.
87. Ozer S, Ulusahin A, Ulusoy S, Okur H, Coskun T, Tuncali T, et al. (2004). Is vitamin D hypothesis for schizophrenia valid? Independent segregation of psychosis in a family with vitamin-D-dependent rickets type IIA. Prog Neuropsycho-pharmacol Biol Psychiatry 28:255-266.
88. Prufer K, Veenstra TD, Jirikowski GF, Kumar R (1999). Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 16:135-145.
89. Przybelski RJ, Binkley NC (2007). Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 460:202-205.
90. Reichel H, Norman AW (1989). Systemic effects of vitamin D. Annu Rev Med 40:71-78.
91. Saha S, Chant DC, Welham JL, McGrath JJ (2006). The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatr Scand 114:36-39.
92. Sato Y, Asoh T, Oizumi K (1998). High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 23:555-557.
93. Sato Y, Metoki N, Iwamoto J, Satoh K (2003). Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients. Neurology 61:338-342.
94. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 73:49-62.
95. Senoglu M, Tuncel D, Orhan F, Yuksel Z, Gokce M (2007). Fahr's Syndrome: a report of two cases. Firat Tip Dergisi 12:70-72.
96. Shipowick CD, Moore CB, Corbett C, Bindler R (2009). Vitamin D and depressive symptoms in women during the winter: a pilot study. Appl Nurs Res 22:221-225.
97. Shirani A, St Louis EK (2009). Illuminating rationale and uses for light therapy. J Clin Sleep Med 5:155-163.
98. Siegel A, Malkowitz L, Moskovits MJ, Christakos S (1984). Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res 298:125-129.
99. Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J (2009). The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 8:621-626.
100. St-Arnaud R (2008). The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys 473:225-230.
101. Stumpf WE, O'Brien LP (1987). 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 87:393-406.
102. Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR (1998). Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem 273:8483-8491.
103. Torrey EF, Miller J (1997). Season of birth and schizophrenia: southern hemisphere data. Aust N Z J Psychiatry 31:308-309.
104. Tuohimaa P (2009). Vitamin D and aging. J Steroid Biochem Mol Biol 114:78-84.
105. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A (2009). Vitamin D, nervous system and aging. Psychoneuroendocrinology 34 (Suppl 1):S278-S286.
106. Tysiewicz-Dudek M, Pietraszkiewicz F, Drozdzowska B (2008). Alzheimer's disease and osteoporosis: common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil 10:315-323.
107. Veng LM, Mesches MH, Browning MD (2003). Age-related working memory impairment is correlated with increases in the L-type calcium channel protein alpha1D (Cav1.3) in area CA1 of the hippocampus and both are ameliorated by chronic nimodipine treatment. Brain Res Mol Brain Res 110:193-202.
108. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, et al. (2005). Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19:2685-2695.
109. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006). Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14:1032-1040.
110. Wilkins CH, Birge SJ, Sheline YI, Morris JC (2009). Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 101:349-354.
111. Yan J, Feng J, Craddock N, Jones IR, Cook EH Jr, Goldman D, et al. (2005). Vitamin D receptor variants in 192 patients with schizophrenia and other psychiatric diseases. Neurosci Lett 380:37-41.
112. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. (1997). Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396.